Fresenius Med Care Maple Grove is categorized under Kidney Dialysis Centers in Osseo, MN .
Fresenius Med Care Maple Grove was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Kris Prescott, Manager at the company’s single location by writing to 7365 Kirkwood Court North # 335, Osseo, Minnesota MN 55369 or by phoning (763) 494-0316. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Fresenius Med Care Maple Grove |
Contact Person: | Kris Prescott, Manager |
Address: | 7365 Kirkwood Court North # 335, Osseo, Minnesota 55369 |
Phone Number: | (763) 494-0316 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Kidney Dialysis Centers |
SIC Code: | 8092 |
NAICS Code: | 6214930 |
Share This Business: |
Fresenius Med Care Maple Grove was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Kris Prescott, Manager for inquiries that concern Fresenius Med Care Maple Grove by calling the company number (763) 494-0316, as your correspondence is most welcome. Additionally, the physical location of the single location of Fresenius Med Care Maple Grove can be found at the coordinates 45.08887,-93.434011 as well as the street address 7365 Kirkwood Court North # 335 in Osseo, Minnesota 55369.
For its online presence, you may visit Fresenius Med Care Maple Grove’s website at and engage with its social media outlets through on Twitter and on Facebook.